Engerix-B (hepatitis B vaccine recombinant) / GSK 
Welcome,         Profile    Billing    Logout  
 68 Diseases   21 Trials   21 Trials   291 News 
19 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Engerix-B (hepatitis B vaccine recombinant) / GSK
2011-000923-33: Effects of paracetamol use on the immune response after hepatitis B vaccination

Ongoing
4
138
Europe
Engerix-B, Paracetamol, Engerix-B, Paracetamol
Rijksinstituut voor Volksgezondheid en Milieu (RIVM), National Institute for Public Health and the Environment
No medical conditions will be studied. The association between timing of the use of paracetamol during hepatitis B vaccination and the development of an antibody response will be studied in students that are vaccinated with the hepatitis B vaccin as part of their healthcare training.
 
 
2011-005627-40: Comparison of 4 different Hepatitis B vaccines in healthy persons in whom a standard hepatitis B vaccination schedule of three vaccinations did not induces a protective immune response, so-called non-responders. Vergelijking van 4 verschillende hepatitis B vaccins in gezonde personen die na een standaard serie hepatitis B vaccinaties (3 vaccinaties) geen beschermende afweerreactie hebben opgebouwd, de non-responders.

Ongoing
4
480
Europe
HBVAXPRO, Fendrix, Twinrix, Engerix-B, HBVAXPRO-10, HBVAXPRO-40, Fendrix, Twinrix, Engerix-B, HBVAXPRO-10, HBVAXPRO-40, Fendrix, Twinrix, Engerix-B
previous non-response to hepatitis B vaccine (3 vaccinations, standard schedule) voorheen non-responders op hepatitis B vaccinatie schema (3 vaccinaties, stadaarnd schema)
 
 
2017-004069-29: Study to Describe Persistence of Hepatitis B Antibodies in Children Vaccinated with a Hexavalent Vaccine and to Evaluate Their Immune Memory Following a Vaccination with Hepatitis B Vaccine

Ongoing
4
487
Europe
Engerix B, Suspension for injection in pre-filled syringe, Engerix B
Sanofi Pasteur, Sanofi Pasteur
challenge dose of Engerix B to assess the quality of the persisting immune memory against hepatitis B in children aged 6 to 7 years, challenge dose of Engerix B to assess the quality of the persisting immune memory against hepatitis B in children aged 6 to 7 years, Diseases [C] - Bacterial Infections and Mycoses [C01]
 
 
NCT04326803: Hepatitis B en Haitian Immigrants in Chile: Molecular Characterization and Determination of Vaccine Response

Not yet recruiting
4
200
NA
Hepatitis B recombinant vaccine, Engerix-B vaccine
Pontificia Universidad Catolica de Chile
Hepatitis B
06/22
12/23
NCT03854630: Hepatitis B Virus Vaccination in HIV-positive Patients and Individuals at High Risk for HIV Infection

Recruiting
4
575
RoW
Engerix-B
National Taiwan University Hospital, Taipei Veterans General Hospital, Taiwan
Viral Hepatitis B, Immunization; Infection, HIV Infections
06/23
12/23
COMBAT-HBV, NCT05705427: The COMBAT HBV Feasibility Trial

Recruiting
4
560
RoW
Tenofovir Disoproxil Fumarate 300 MG, Viread, Hepatitis B monovalent vaccine, Hepatitis B birth-dose vaccine, Engerix-B, Placebo
University of North Carolina, Chapel Hill, Doris Duke Charitable Foundation, Université Protestant au Congo, Abbott, Albert Einstein College of Medicine
Hepatitis B, Vertical Transmission of Infectious Disease
08/25
08/25
2010-023947-14: Prospective, Randomized and Comparative Study to evaluate the efficacy of two vaccines against Hepatitis B virus in inflammatory bowel disease patients ENSAYO CLÍNICO MULTICÉNTRICO, PROSPECTIVO, ALEATORIZADO Y COMPARATIVO PARA EVALUAR LA EFICACIA DE DOS VACUNAS FRENTE AL VIRUS DE LA HEPATITIS B EN PACIENTES CON ENFERMEDAD INFLAMATORIA INTESTINAL

Ongoing
3
236
Europe
FENDRIX, Not Applicable, ENGERIX-B 20µg / 1ml suspensión inyectable en jeringa precargada, FENDRIX, suspensión inyectable, ENGERIX-B 20µg / 1ml suspensión inyectable en jeringa precargada, FENDRIX, suspensión inyectable
Hospital Universitario La Princesa, Hospital Universitario La Princesa
Prophylaxis against Hepatitis B virus Profilaxis contra el virus de la hepatitis B
 
 
BEe-HIVe, NCT04193189: B-Enhancement of HBV Vaccination in Persons Living With HIV (): Evaluation of HEPLISAV-B

Completed
3
640
US, RoW
HEPLISAV-B, ENGERIX-B
National Institute of Allergy and Infectious Diseases (NIAID), Dynavax Technologies Corporation
HIV Infection, Hepatitis B
08/24
08/24
NCT03537508 / 2018-001473-24: Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers in the US

Hourglass Jan 2023 - Dec 2023 : Data from P3 trial for meningococcal infections
Completed
3
2627
US
MenACYW conjugate vaccine, MenACYW-135 conjugate vaccine, MENVEO®, DTaP-IPV//Hib vaccine, Pentacel®, Pneumococcal 13-valent conjugate vaccine, PREVNAR 13®, Pentavalent rotavirus vaccine, RotaTeq®, Hepatitis B vaccine, ENGERIX-B®, Measles, mumps, rubella (MMR) vaccine, M-M-R® II, Varicella vaccine, VARIVAX®, Hepatitis A vaccine, HAVRIX®
Sanofi Pasteur, a Sanofi Company
Healthy Volunteers (Meningococcal Infection)
09/23
09/23
2010-023946-58: Immunogenicity and safety of an adjuvant hepatitis B vaccine (fendrix) compared to Engerix in non-responding HIV-infected patients

Ongoing
2
100
Europe
Fendrix, Fendrix
ErasmusMC
We want to study the efficacy of Fendrix, a new adjuvant hepatitis B vaccin, in HIV infected patients, who failed to respond on intial standard and subsequent booster Hepatitis b vaccinations. We want to compare the efficacy of Fendrix to the efficacy of a double dose of the standard hepatitis b vaccinations, Engerix
 
 
2021-000644-22: Effectiveness and Safety of Intra-Dermal Hepatitis B Vaccination after a local application of cream, called IMIQUIMOD, in cirrhotic patients who did not respond to the conventional (intra-muscular) vaccine regimen. Efficacité et Sécurité de la Vaccination contre l’hépatite B en intra-dermique après une application locale de crème, appelée IMIQUIMOD, chez les patients cirrhotiques, n'ayant pas répondus au schéma vaccinal classique ( intra -musculaire )

Not yet recruiting
2
60
Europe
ENGERIX B 20 microgrammes/1 ml, Cream, Solution for injection, ALDARA, ENGERIX B 20 microgrammes/1 ml
CHRU de Nancy, CHRU de Nancy
Cirrhotic patients who have already received a HBV vaccination with a conventional regimen and who have not responded (characterized by a level of antibody Hbs < 10UI/ml at the end of the vaccine regimen). Patients cirrhotiques ayant déjà bénéficié d’une vaccination contre le VHB avec un schéma classique et n’ayant pas répondu (caractérisé par un taux d’anticorps anti Hbs < 10UI/ml la fin du schéma vaccinal), Cirrhotic patients who have already received a HBV vaccination with a conventional regimen and who have not responded Patients cirrhotiques ayant déjà bénéficié d’une vaccination contre le VHB avec un schéma classique et n’ayant pas répondu, Diseases [C] - Immune System Diseases [C20]
 
 
NCT04398706: Study of a Pneumococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Toddlers and Infants

Completed
2
852
Canada, US, RoW
Pneumococcal Conjugate Vaccine formulation 1, SP0202-IIb, Pneumococcal Conjugate Vaccine formulation 2, SP0202-VI, Pneumococcal Conjugate Vaccine formulation 3, SP0202-VII, Varicella Virus Vaccine Live, Varicella vaccine, VARIVAX®, Measles, Mumps, and Rubella Virus Vaccine Live, MMR vaccine, M-M-R ®II, Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein], Prevnar 13®, Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus and Haemophilus b Conjugate (Tetanus Toxoid Conjugate), DTaP-IPV// Hib vaccine, Pentacel®, Rotavirus Vaccine, Live, Oral, Pentavalent, Rotavirus vaccine, RotaTeq, Hepatitis B Vaccine* [Recombinant] *as applicable, Hepatitis B vaccine, ENGERIX-B®
Sanofi Pasteur, a Sanofi Company
Pneumococcal Immunisation, Diphtheria Immunisation, Tetanus Immunisation, Pertussis Immunisation, Hepatitis B Immunisation, Haemophilus Influenzae Type b Immunisation, Polio Immunisation, Measles Immunisation, Rubella Immunisation, Varicella Immunisation, Mumps Immunisation
08/23
08/23
2021-005629-25: A study on the safety and immune response of AS37 together with Hepatitis B antigen in adults aged 18-45 years

Not yet recruiting
1/2
150
Europe
GSKVx000000030242, GSKVx000000030083, GSKVx000000030451, Powder and suspension for suspension for injection, Suspension for injection, Emulsion for emulsion for injection, Fendrix, Engerix-B Erwachsene
GlaxoSmithKline Biologicals SA, GlaxoSmithKline Biologicals, GlaxoSmithKline Biologicals SA
Healthy volunteers (Hepatitis B Virus infection), Hepatitis B virus (HBV) infection, especially chronic infection, is a significant worldwide medical problem that affects the liver, Diseases [C] - Virus Diseases [C02]
 
 
NCT05561673 / 2021-005629-25: A Study on the Safety and Immune Response of AS37 Together With Hepatitis B Antigen in Adults Aged 18-45 Years

Completed
1/2
122
Europe
GSK's Hepatitis B vaccine adjuvanted with aluminum hydroxide, Engerix-B, GSK's HBsAg candidate vaccine adjuvanted with GSK's AS03 adjuvant system, GSK's Hepatitis B vaccine adjuvanted with GSK's AS04 adjuvant system, Fendrix, GSK's HBsAg vaccine adjuvanted with GSK's AS37 adjuvant system formulation 1, GSK's HBsAg vaccine adjuvanted with GSK's AS37 adjuvant system formulation 2
GlaxoSmithKline, GlaxoSmithKline Biologicals, GlaxoSmithKline Biologicals SA
Hepatitis B
11/24
11/24
NCT03910972: Sm-TSP-2 Schistosomiasis Vaccine in Healthy Ugandan Adults

Active, not recruiting
1/2
290
RoW
Sm-TSP-2/Alhydrogel® vaccine, Sm-TSP-2/Alhydrogel® vaccine plus AP 10-701, ENGERIX-B Hepatitis B Vaccine
Baylor College of Medicine, George Washington University, Makerere University Walter Reed Project
Schistosomiasis, Schistosoma Mansoni
11/24
09/25
HBV003, NCT03038802: A Randomised Controlled Phase 1 Study of Vaccine Therapy for Control or Cure of Chronic Hepatitis B Virus Infection

Not yet recruiting
1/2
40
RoW
Therapeutic hepatitis B vaccine, Hepadvax(TM), Commercial Hepatitis B vaccine, Engerix B
Vaxine Pty Ltd, Australian Respiratory and Sleep Medicine Institute
Chronic Hepatitis b
12/25
12/26
NCT06515938: Study on New Strategies for Hepatitis B Virus Immunization

Completed
N/A
1169
RoW
20μg Engerix-B hepatitis B vaccine, 20μg Kangtai hepatitis B vaccine, 60μg Kangtai hepatitis B vaccine, 20μg CHO
Wu Jiang
Vaccine Reaction
06/14
12/15
PROTECT, NCT05200338: Preservation and Transfer of HBV Immunity After Allogeneic HSCT for SCD

Recruiting
N/A
30
Europe
Engerix-B
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Sickle Cell Disease
01/24
12/24
IRHBRVD, NCT04970836: The Immune Responses After Hepatitis B Revaccination Doses in a Young Cohort

Recruiting
N/A
240
RoW
recombinant hepatitis B vaccine, Engerix-B
National Taiwan University Hospital, Academia Sinica, Taiwan, Ministry of Science and Technology, Taiwan
Hepatitis B, Vaccination; Infection, Preventable Disease, Vaccine
12/27
12/27
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Engerix-B (hepatitis B vaccine recombinant) / GSK
2011-000923-33: Effects of paracetamol use on the immune response after hepatitis B vaccination

Ongoing
4
138
Europe
Engerix-B, Paracetamol, Engerix-B, Paracetamol
Rijksinstituut voor Volksgezondheid en Milieu (RIVM), National Institute for Public Health and the Environment
No medical conditions will be studied. The association between timing of the use of paracetamol during hepatitis B vaccination and the development of an antibody response will be studied in students that are vaccinated with the hepatitis B vaccin as part of their healthcare training.
 
 
2011-005627-40: Comparison of 4 different Hepatitis B vaccines in healthy persons in whom a standard hepatitis B vaccination schedule of three vaccinations did not induces a protective immune response, so-called non-responders. Vergelijking van 4 verschillende hepatitis B vaccins in gezonde personen die na een standaard serie hepatitis B vaccinaties (3 vaccinaties) geen beschermende afweerreactie hebben opgebouwd, de non-responders.

Ongoing
4
480
Europe
HBVAXPRO, Fendrix, Twinrix, Engerix-B, HBVAXPRO-10, HBVAXPRO-40, Fendrix, Twinrix, Engerix-B, HBVAXPRO-10, HBVAXPRO-40, Fendrix, Twinrix, Engerix-B
previous non-response to hepatitis B vaccine (3 vaccinations, standard schedule) voorheen non-responders op hepatitis B vaccinatie schema (3 vaccinaties, stadaarnd schema)
 
 
2017-004069-29: Study to Describe Persistence of Hepatitis B Antibodies in Children Vaccinated with a Hexavalent Vaccine and to Evaluate Their Immune Memory Following a Vaccination with Hepatitis B Vaccine

Ongoing
4
487
Europe
Engerix B, Suspension for injection in pre-filled syringe, Engerix B
Sanofi Pasteur, Sanofi Pasteur
challenge dose of Engerix B to assess the quality of the persisting immune memory against hepatitis B in children aged 6 to 7 years, challenge dose of Engerix B to assess the quality of the persisting immune memory against hepatitis B in children aged 6 to 7 years, Diseases [C] - Bacterial Infections and Mycoses [C01]
 
 
NCT04326803: Hepatitis B en Haitian Immigrants in Chile: Molecular Characterization and Determination of Vaccine Response

Not yet recruiting
4
200
NA
Hepatitis B recombinant vaccine, Engerix-B vaccine
Pontificia Universidad Catolica de Chile
Hepatitis B
06/22
12/23
NCT03854630: Hepatitis B Virus Vaccination in HIV-positive Patients and Individuals at High Risk for HIV Infection

Recruiting
4
575
RoW
Engerix-B
National Taiwan University Hospital, Taipei Veterans General Hospital, Taiwan
Viral Hepatitis B, Immunization; Infection, HIV Infections
06/23
12/23
COMBAT-HBV, NCT05705427: The COMBAT HBV Feasibility Trial

Recruiting
4
560
RoW
Tenofovir Disoproxil Fumarate 300 MG, Viread, Hepatitis B monovalent vaccine, Hepatitis B birth-dose vaccine, Engerix-B, Placebo
University of North Carolina, Chapel Hill, Doris Duke Charitable Foundation, Université Protestant au Congo, Abbott, Albert Einstein College of Medicine
Hepatitis B, Vertical Transmission of Infectious Disease
08/25
08/25
2010-023947-14: Prospective, Randomized and Comparative Study to evaluate the efficacy of two vaccines against Hepatitis B virus in inflammatory bowel disease patients ENSAYO CLÍNICO MULTICÉNTRICO, PROSPECTIVO, ALEATORIZADO Y COMPARATIVO PARA EVALUAR LA EFICACIA DE DOS VACUNAS FRENTE AL VIRUS DE LA HEPATITIS B EN PACIENTES CON ENFERMEDAD INFLAMATORIA INTESTINAL

Ongoing
3
236
Europe
FENDRIX, Not Applicable, ENGERIX-B 20µg / 1ml suspensión inyectable en jeringa precargada, FENDRIX, suspensión inyectable, ENGERIX-B 20µg / 1ml suspensión inyectable en jeringa precargada, FENDRIX, suspensión inyectable
Hospital Universitario La Princesa, Hospital Universitario La Princesa
Prophylaxis against Hepatitis B virus Profilaxis contra el virus de la hepatitis B
 
 
BEe-HIVe, NCT04193189: B-Enhancement of HBV Vaccination in Persons Living With HIV (): Evaluation of HEPLISAV-B

Completed
3
640
US, RoW
HEPLISAV-B, ENGERIX-B
National Institute of Allergy and Infectious Diseases (NIAID), Dynavax Technologies Corporation
HIV Infection, Hepatitis B
08/24
08/24
NCT03537508 / 2018-001473-24: Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers in the US

Hourglass Jan 2023 - Dec 2023 : Data from P3 trial for meningococcal infections
Completed
3
2627
US
MenACYW conjugate vaccine, MenACYW-135 conjugate vaccine, MENVEO®, DTaP-IPV//Hib vaccine, Pentacel®, Pneumococcal 13-valent conjugate vaccine, PREVNAR 13®, Pentavalent rotavirus vaccine, RotaTeq®, Hepatitis B vaccine, ENGERIX-B®, Measles, mumps, rubella (MMR) vaccine, M-M-R® II, Varicella vaccine, VARIVAX®, Hepatitis A vaccine, HAVRIX®
Sanofi Pasteur, a Sanofi Company
Healthy Volunteers (Meningococcal Infection)
09/23
09/23
2010-023946-58: Immunogenicity and safety of an adjuvant hepatitis B vaccine (fendrix) compared to Engerix in non-responding HIV-infected patients

Ongoing
2
100
Europe
Fendrix, Fendrix
ErasmusMC
We want to study the efficacy of Fendrix, a new adjuvant hepatitis B vaccin, in HIV infected patients, who failed to respond on intial standard and subsequent booster Hepatitis b vaccinations. We want to compare the efficacy of Fendrix to the efficacy of a double dose of the standard hepatitis b vaccinations, Engerix
 
 
2021-000644-22: Effectiveness and Safety of Intra-Dermal Hepatitis B Vaccination after a local application of cream, called IMIQUIMOD, in cirrhotic patients who did not respond to the conventional (intra-muscular) vaccine regimen. Efficacité et Sécurité de la Vaccination contre l’hépatite B en intra-dermique après une application locale de crème, appelée IMIQUIMOD, chez les patients cirrhotiques, n'ayant pas répondus au schéma vaccinal classique ( intra -musculaire )

Not yet recruiting
2
60
Europe
ENGERIX B 20 microgrammes/1 ml, Cream, Solution for injection, ALDARA, ENGERIX B 20 microgrammes/1 ml
CHRU de Nancy, CHRU de Nancy
Cirrhotic patients who have already received a HBV vaccination with a conventional regimen and who have not responded (characterized by a level of antibody Hbs < 10UI/ml at the end of the vaccine regimen). Patients cirrhotiques ayant déjà bénéficié d’une vaccination contre le VHB avec un schéma classique et n’ayant pas répondu (caractérisé par un taux d’anticorps anti Hbs < 10UI/ml la fin du schéma vaccinal), Cirrhotic patients who have already received a HBV vaccination with a conventional regimen and who have not responded Patients cirrhotiques ayant déjà bénéficié d’une vaccination contre le VHB avec un schéma classique et n’ayant pas répondu, Diseases [C] - Immune System Diseases [C20]
 
 
NCT04398706: Study of a Pneumococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Toddlers and Infants

Completed
2
852
Canada, US, RoW
Pneumococcal Conjugate Vaccine formulation 1, SP0202-IIb, Pneumococcal Conjugate Vaccine formulation 2, SP0202-VI, Pneumococcal Conjugate Vaccine formulation 3, SP0202-VII, Varicella Virus Vaccine Live, Varicella vaccine, VARIVAX®, Measles, Mumps, and Rubella Virus Vaccine Live, MMR vaccine, M-M-R ®II, Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein], Prevnar 13®, Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus and Haemophilus b Conjugate (Tetanus Toxoid Conjugate), DTaP-IPV// Hib vaccine, Pentacel®, Rotavirus Vaccine, Live, Oral, Pentavalent, Rotavirus vaccine, RotaTeq, Hepatitis B Vaccine* [Recombinant] *as applicable, Hepatitis B vaccine, ENGERIX-B®
Sanofi Pasteur, a Sanofi Company
Pneumococcal Immunisation, Diphtheria Immunisation, Tetanus Immunisation, Pertussis Immunisation, Hepatitis B Immunisation, Haemophilus Influenzae Type b Immunisation, Polio Immunisation, Measles Immunisation, Rubella Immunisation, Varicella Immunisation, Mumps Immunisation
08/23
08/23
2021-005629-25: A study on the safety and immune response of AS37 together with Hepatitis B antigen in adults aged 18-45 years

Not yet recruiting
1/2
150
Europe
GSKVx000000030242, GSKVx000000030083, GSKVx000000030451, Powder and suspension for suspension for injection, Suspension for injection, Emulsion for emulsion for injection, Fendrix, Engerix-B Erwachsene
GlaxoSmithKline Biologicals SA, GlaxoSmithKline Biologicals, GlaxoSmithKline Biologicals SA
Healthy volunteers (Hepatitis B Virus infection), Hepatitis B virus (HBV) infection, especially chronic infection, is a significant worldwide medical problem that affects the liver, Diseases [C] - Virus Diseases [C02]
 
 
NCT05561673 / 2021-005629-25: A Study on the Safety and Immune Response of AS37 Together With Hepatitis B Antigen in Adults Aged 18-45 Years

Completed
1/2
122
Europe
GSK's Hepatitis B vaccine adjuvanted with aluminum hydroxide, Engerix-B, GSK's HBsAg candidate vaccine adjuvanted with GSK's AS03 adjuvant system, GSK's Hepatitis B vaccine adjuvanted with GSK's AS04 adjuvant system, Fendrix, GSK's HBsAg vaccine adjuvanted with GSK's AS37 adjuvant system formulation 1, GSK's HBsAg vaccine adjuvanted with GSK's AS37 adjuvant system formulation 2
GlaxoSmithKline, GlaxoSmithKline Biologicals, GlaxoSmithKline Biologicals SA
Hepatitis B
11/24
11/24
NCT03910972: Sm-TSP-2 Schistosomiasis Vaccine in Healthy Ugandan Adults

Active, not recruiting
1/2
290
RoW
Sm-TSP-2/Alhydrogel® vaccine, Sm-TSP-2/Alhydrogel® vaccine plus AP 10-701, ENGERIX-B Hepatitis B Vaccine
Baylor College of Medicine, George Washington University, Makerere University Walter Reed Project
Schistosomiasis, Schistosoma Mansoni
11/24
09/25
HBV003, NCT03038802: A Randomised Controlled Phase 1 Study of Vaccine Therapy for Control or Cure of Chronic Hepatitis B Virus Infection

Not yet recruiting
1/2
40
RoW
Therapeutic hepatitis B vaccine, Hepadvax(TM), Commercial Hepatitis B vaccine, Engerix B
Vaxine Pty Ltd, Australian Respiratory and Sleep Medicine Institute
Chronic Hepatitis b
12/25
12/26
NCT06515938: Study on New Strategies for Hepatitis B Virus Immunization

Completed
N/A
1169
RoW
20μg Engerix-B hepatitis B vaccine, 20μg Kangtai hepatitis B vaccine, 60μg Kangtai hepatitis B vaccine, 20μg CHO
Wu Jiang
Vaccine Reaction
06/14
12/15
PROTECT, NCT05200338: Preservation and Transfer of HBV Immunity After Allogeneic HSCT for SCD

Recruiting
N/A
30
Europe
Engerix-B
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Sickle Cell Disease
01/24
12/24
IRHBRVD, NCT04970836: The Immune Responses After Hepatitis B Revaccination Doses in a Young Cohort

Recruiting
N/A
240
RoW
recombinant hepatitis B vaccine, Engerix-B
National Taiwan University Hospital, Academia Sinica, Taiwan, Ministry of Science and Technology, Taiwan
Hepatitis B, Vaccination; Infection, Preventable Disease, Vaccine
12/27
12/27

Download Options